CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 196 participants.

Also called NCT03716934

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 196 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03716934
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03716934. Randomized; single masking; primary purpose treatment. Start 2018-06-27 (actual); primary completion 2022-04-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial
Acronym
craft
Intervention (Device)
Arctic Front Advance® balloon catheter
Intervention (Drug)
Antiarrhythmic drug
Intervention (Device)
Confirm RX heart monitor® (Abbott)
Lead sponsor
Hospital San Carlos, Madrid (class: other)

Record details

Record id
cardio:ct-nct03716934
Content hash
d70a403757f9e176ac9dd8e688c9cae6576f133bc650cfb9ff456b1107ba71ee